Medical Advisory Board additions support company’s growing product offerings across women’s health and family building. NEW ...

The Company is quickly advancing both its Marijuana Breath Test (MBT) with key validation work established in March, and its ...

Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...

Goldberg will sit down with CNBC’s Tim Seymour on Wednesday, June 4, for an exclusive conversation in the Special Events Area on the CMB exhibit floor. The discussion will dive into the fast-rising ...

Ramsay Santé Group reported a consolidated revenue of €3,889m for the nine months period ending 31 March 2025, up 5.1% on a reported basis. Adjusted for changes in the consolidation scope and at ...

Natural Chromium Picolinate- this ingredient helps you control hunger and food cravings. Additionally, it makes your system ...

ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.

Columbia University, the Company’s collaboration partner for pre-clinical development, granted Silo an exclusive global license to further develop, manufacture, and commercialize SPC-15 worldwide.

Internationally acclaimed neurologist and epilepsy researcher Dr. Orrin Devinsky will be honored with the Lifetime Accelerator Award during the Epilepsy Therapies & Diagnostics Development Symposium ...

Menopausal support (energy, mood, muscle retention): creatine is a woman’s powerful ally during the menopause face as it ...

SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt ...

Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect ...